Occupational Therapists in South Windsor, CT Accepting Medicare
9 Occupational Therapists found. Showing 1 - 9
 Jennifer Bellody Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 158 Orchard Hill Dr, South Windsor, CT 06074 Phone: 860-306-1240 |
Beata Russo, M.ED, OTR/L Occupational Therapist - Hand Medicare: Accepting Medicare Assignments Practice Location: 561 King St, South Windsor, CT 06074 Phone: 860-969-0207 |
 Russo Therapeutics, Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 561 King Street, South Windsor, CT 06074 Phone: 860-969-0207 Fax: 833-491-0465 |
Margaret Carey Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Evergreen Way, South Windsor, CT 06074 Phone: 860-851-9328 |
Madelyn Rae Bedard, MOT, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 915 Sullivan Ave Ste 3, South Windsor, CT 06074 Phone: 860-644-2335 |
Bonita Sonya Austin Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Deming St, South Windsor, CT 06074 Phone: 860-922-7333 |
Sarah Ashley Farnsworth, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 491 Buckland Rd, South Windsor, CT 06074 Phone: 860-788-5515 |
 Curtis Manganello, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Evergreen Way, South Windsor, CT 06074 Phone: 860-851-9328 Fax: 847-730-2490 |
Whitney Ann Burns, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 261 Oakland Rd, South Windsor, CT 06074 Phone: 860-969-0207 |
News Archive
Pioneering work by Swansea University professor becomes most cited article in Desalination journal
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
Larger portion of Africa at high risk for malaria transmission
A larger portion of Africa is currently at high risk for malaria transmission than previously predicted, according to a new University of Florida mapping study.
BAHA fitting linked with greater benefit and higher quality of life in children with hearing loss
Bone-anchored hearing aids appear helpful in improving hearing and quality of life in children with hearing loss in one or both ears, according to a report in the February issue of Archives of Otolaryngology - Head & Neck Surgery, one of the JAMA/Archives journals.
› Verified 6 days ago
Physical Therapists
Chiropractors
Optometrists
Speech-Language Pathologists
Occupational Therapists
Audiologists
Podiatrists